美年健康(002044.SZ)：子公司拟受让股权投资基金份额

Group 1 - The company announced that its wholly-owned subsidiary, Meinian Chuangxin, signed a share transfer agreement to acquire a 16.6667% limited partnership interest in the Guangzhou Qiaoxin Shengjing No.1 Venture Capital Partnership, corresponding to a subscribed capital contribution of RMB 10 million, with a paid-in capital of RMB 0 [1] - The total subscribed capital contribution for the partnership is RMB 60 million, with Meinian Chuangxin contributing RMB 10 million, representing 16.6667% of the total [1] - The investment is part of the company's "ALL in AI" strategy, aimed at leveraging professional investment operations to seize opportunities in AI technology and key industry applications, enhancing overall competitiveness and promoting long-term development [2]